A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
about
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicityTeicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureusRight-sided endocarditis caused by Staphylococcus aureus in drug abusers.Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance dosesRandomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters.Population pharmacokinetics of teicoplanin in patients with endocarditis.Teicoplanin in perspective. A critical comparison with vancomycin.Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses.Teicoplanin: 10 years of clinical experience.Anti-infective treatment in intensive care: the role of glycopeptides.Glycopeptides and nephrotoxicity.Use of teicoplanin in community medicine.Treatment failure with teicoplanin and response to oral antibiotic regimens.Efficacy of femoral intra-arterial administration of teicoplanin in gram-positive diabetic foot infections.
P2860
Q28326763-F7F38472-9687-41FA-907F-699DCEC79F0FQ33756241-1D400504-A027-4AE2-B40A-F8DFA20990FCQ35111909-8F1D6387-0CE4-4403-A79F-DBC1B87D9DBAQ35280642-EE5F1E61-1D65-46B8-9A6A-E2A53B7FD77DQ35341106-C543649B-66BF-49FE-B040-0BD5D6A9D126Q36792782-4116F99E-6C6F-4107-9416-D7BBBB4D440BQ37113420-64F04281-AA88-4749-A69E-19CBD37CAE46Q39814923-B3D08ADF-F240-4150-8CFA-E3EE11BD50C1Q39815914-19B7415E-1F38-4F20-9B50-86E2503BA309Q40088301-05BCEA30-4814-43AA-B9AC-AC5C19A64FD8Q40495612-AC8D7B5E-C2EE-4461-B6F4-00EDB8F2185BQ40495770-DC1172F9-F892-4672-BF8A-300D92850EFEQ40495778-2DE4A7DA-D11E-4DA3-97C8-66E7C53881F1Q40584161-CFB0C7F2-B110-4319-8217-7BE81C25886DQ43771971-C11F0EBE-5D79-467C-B5D4-DB6DB1FC3D7EQ54157136-3CABF519-1EA9-4405-BC1A-C1B2BD8D27E4
P2860
A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@en
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@nl
type
label
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@en
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@nl
prefLabel
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@en
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@nl
P2093
P356
P1476
A multicentre open clinical tr ...... sed by gram-positive bacteria.
@en
P2093
P356
10.1093/JAC/21.SUPPL_A.61
P407
P478
21 Suppl A
P577
1988-01-01T00:00:00Z